home / stock / kpti / kpti news


KPTI News and Press, Karyopharm Therapeutics Inc. From 03/02/22

Stock Information

Company Name: Karyopharm Therapeutics Inc.
Stock Symbol: KPTI
Market: NASDAQ
Website: karyopharm.com

Menu

KPTI KPTI Quote KPTI Short KPTI News KPTI Articles KPTI Message Board
Get KPTI Alerts

News, Short Squeeze, Breakout and More Instantly...

KPTI - Organogenesis, CytomX top healthcare gainers; Karyopharm Bright Health lead losers' pack

Gainers: Organogenesis (NASDAQ:ORGO) +24%. CytomX Therapeutics (NASDAQ:CTMX) +13%. X4 Pharmaceuticals (NASDAQ:XFOR) +13%. MannKind (NASDAQ:MNKD) +10%. Allied Healthcare (NASDAQ:AHPI) +6%. Losers: Karyopharm Therapeutics (NASDAQ:KPTI) -31%. Bright Health Grou...

KPTI - Karyopharm sinks on setback for U.S. label expansion of cancer therapy

The shares of the commercial-stage pharmaceutical company, Karyopharm Therapeutics (NASDAQ:KPTI) have lost ~28% in the pre-market Wednesday amid concerns that the company will need another trial to support its request for U.S. label expansion of cancer therapy, Xpovio (selinexor). F...

KPTI - ZIMV, KPTI and HOOK among after hour movers

Gainers: SoFi Technologies SOFI +20%. Scientific Games Corp SGMS +10%. CytomX Therapeutics CTMX +10%. ZimVie  (ZIMV) +9%. PLBY Group PLBY +9%. Losers: Karyopharm Therapeutics  (NASDAQ:KPTI) -27%. HOOKIPA Pharma  HOOK -20%. Proterra PTRA -...

KPTI - Karyopharm Provides U.S. Regulatory Update on Selinexor in Advanced or Recurrent Endometrial Cancer

Karyopharm Provides U.S. Regulatory Update on Selinexor in Advanced or Recurrent Endometrial Cancer Following Discussion with the FDA, Karyopharm Plans to Initiate a New Placebo-Controlled Randomized Study of Selinexor in the Advanced or Recurrent Endometrial Cancer p53 Wild-Typ...

KPTI - Here's Why Karyopharm Therapeutics Is Sliding on Tuesday

Shares of Karyopharm Therapeutics (NASDAQ: KPTI) , a biopharmaceutical company developing new cancer drugs, are tanking Tuesday as investors respond to an unexpected leadership change. The stock was trading 30.5% lower as of 11:52 a.m. ET. On Feb. 8, shares of Karyopharm s...

KPTI - IRNT, FAT and DTSS among mid-day movers

Gainers: Indonesia (NYSE:INDO) +79%. Meritor (NYSE:MTOR) +45%. Ocugen (NASDAQ:OCGN) +22%. Datasea (NASDAQ:DTSS) +20%. IronNet (NYSE:IRNT) +20%. Riley Exploration Permian (NYSE:REPX) +19%. Arteris (NASDAQ:AIP) +17%. Houghton Mifflin Harcourt Company (NASDAQ:HMHC) +15%. MEDIROM Healthcare Techn...

KPTI - HOOKIPA, Nuvectis top healthcare gainers; Allarity, Homology Medicines lead losers' pack

Gainers: HOOKIPA Pharma HOOK +18%. Nuvectis Pharma (NASDAQ:NVCT) +16%. Ocugen OCGN +14%. Privia Health (NASDAQ:PRVA) +12%. IMARA (NASDAQ:IMRA) +11%. Losers: Allarity Therapeutics (NASDAQ:ALLR) -29%. Homology Medicines FIXX -27%. Karyopharm The...

KPTI - Yandex, Bilibili, Mobile TeleSystems among premarket losers' pack

Homology Medicines (NASDAQ:FIXX) -25% on FDA clinical hold for phenylketonuria trial. Karyopharm Therapeutics (NASDAQ:KPTI) -23% as medical chief steps down. Inspirato (NASDAQ:ISPO) -17%. QIWI (NASDAQ:QIWI) -14%. Yandex (NASDAQ:YNDX) -13%. Energy Vault (NYSE:NRGV) -12%. Ar...

KPTI - Karyopharm slips as medical chief steps down

Karyopharm Therapeutics (NASDAQ:KPTI) has lost ~24% in the pre-market Tuesday after the company announced that its Executive Vice President and Chief Medical Officer Jatin Shah had decided to step down to pursue other opportunities. However, Dr. Shah will continue to serve the compa...

KPTI - Karyopharm Announces Changes to Its Clinical Leadership Team

Karyopharm Announces Changes to Its Clinical Leadership Team − Patricia Judson, M.D., Formerly of GSK and AstraZeneca, Appointed as Senior Vice President of Medical Strategy - − Stuart Poulton, Formerly of AbbVie, Amgen, and Eli Lilly, Joins as Senior Vice Pres...

Previous 10 Next 10